loader image

Janssen COVID-19 Vaccine (Ad26.COV2-S (recombinant))

 

Regulatory Information

Date

EUA Amendment of Janssen COVID-19 Vaccine

2 August 2022

Product Information

  For Healthcare Providers

  For Vaccine Recipients

For more information on reporting side effects, click here.

Quick Menus

GMP

FDA ACADEMY

DOWNLOADABLES

CAREERS

FAQs

CONTACT US

Recent Posts
Quick Links
Contact Information
Address:

Civic Drive Filinvest Corporate City

Alabang, Muntinlupa City
Tel. no: (02) 8857-1900 local 1000
 
 
 
Landline: 

(02) 8857-1900
local 1000
(02) 8842-5635

Mobile:

09617709691
09616845994
09610574926

Email: [email protected]

Copyright © 2023. All Rights Reserved.

Shares